Filing Details

Accession Number:
0000899243-19-024769
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-02 19:22:47
Reporting Period:
2019-10-01
Accepted Time:
2019-10-02 19:22:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1629137 Global Blood Therapeutics Inc. GBT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238408 Borga Tricia Suvari C/O Global Blood Therapeutics, Inc.
171 Oyster Point Blvd., Suite 300
South San Francisco CA 94080
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-01 3,249 $48.70 13,513 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.